• Je něco špatně v tomto záznamu ?

Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study

S. Strebel, K. Baust, D. Grabow, J. Byrne, T. Langer, A. Am Zehnhoff-Dinnesen, R. Kuonen, A. Weiss, T. Kepak, J. Kruseova, C. Berger, G. Calaminus, G. Sommer, CE. Kuehni, PanCareLIFE Consortium

. 2025 ; 19 (1) : 162-173. [pub] 20230922

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010152

Grantová podpora
602030 European Union's Seventh Framework Program
KLS-3412-02-2014 Krebsliga Schweiz
KFS-4157-02-2017 Swiss Cancer Research Foundation
110298 German Cancer Aid
7E13061 University Hospital of Brno from the Ministry of Education, Youth and Sports of the Czech Republic

PURPOSE: Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL. METHODS: We included CCS from four European countries who were diagnosed at age ≤ 18 years; survived ≥ 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors. RESULTS: Our study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL. CONCLUSION: We observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors. IMPLICATIONS FOR CANCER SURVIVORS: CCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.

Bavarian Care and Nursing Authority Amberg Germany

Boyne Research Institute Drogheda Ireland

CANSEARCH Research Platform in Pediatric Oncology and Hematology Department of Pediatrics Gynecology and Obstetrics University of Geneva Geneva Switzerland

Department for Phoniatrics and Pedaudiology University Hospital Münster Westphalian Wilhems University Münster Germany

Department of BioMedical Research University of Bern Bern Switzerland

Department of Pediatric Endocrinology Diabetology and Metabolism Inselspital Bern University Children's Hospital University of Bern Bern Switzerland

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology University Hospital Bonn Bonn Germany

Department of Pediatric Hematology and Oncology University Hospital Saint Étienne France

Department of Pediatric Oncology and Hematology University Hospital for Children and Adolescents Lübeck Germany

Department of Pediatrics Inselspital Bern University Hospital University of Bern Bern Switzerland

Division of Childhood Cancer Epidemiology German Childhood Cancer Registry Institute of Medical Biostatistics Epidemiology and Informatics University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany

Division of Pediatric Hematology Oncology Department of Pediatrics Inselspital Bern University Hospital University of Bern Bern Switzerland

Graduate School for Health Sciences University of Bern Bern Switzerland

Institute of Social and Preventive Medicine University of Bern Mittelstrasse 43 3012 Bern Switzerland

Lyon University Jean Monnet University INSERM U 1059 Sainbiose Saint Étienne France

University Hospital Brno and International Clinical Research Center Masaryk University Brno Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010152
003      
CZ-PrNML
005      
20250429135539.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11764-023-01456-4 $2 doi
035    __
$a (PubMed)37736773
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Strebel, Sven $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u CANSEARCH Research Platform in Pediatric Oncology and Hematology, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland $u Graduate School for Health Sciences, University of Bern, Bern, Switzerland
245    10
$a Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study / $c S. Strebel, K. Baust, D. Grabow, J. Byrne, T. Langer, A. Am Zehnhoff-Dinnesen, R. Kuonen, A. Weiss, T. Kepak, J. Kruseova, C. Berger, G. Calaminus, G. Sommer, CE. Kuehni, PanCareLIFE Consortium
520    9_
$a PURPOSE: Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL. METHODS: We included CCS from four European countries who were diagnosed at age ≤ 18 years; survived ≥ 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors. RESULTS: Our study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL. CONCLUSION: We observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors. IMPLICATIONS FOR CANCER SURVIVORS: CCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.
650    _2
$a lidé $7 D006801
650    12
$a kvalita života $7 D011788
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a přežívající onkologičtí pacienti $x psychologie $7 D000073116
650    _2
$a dospělí $7 D000328
650    12
$a tinnitus $x etiologie $x epidemiologie $7 D014012
650    12
$a nedoslýchavost $x epidemiologie $x etiologie $7 D034381
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
650    12
$a nádory $x komplikace $x psychologie $7 D009369
650    _2
$a předškolní dítě $7 D002675
650    _2
$a mladý dospělý $7 D055815
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a prevalence $7 D015995
650    _2
$a kohortové studie $7 D015331
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Baust, Katja $u Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany
700    1_
$a Grabow, Desiree $u Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
700    1_
$a Byrne, Julianne $u Boyne Research Institute, Drogheda, Ireland
700    1_
$a Langer, Thorsten $u Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
700    1_
$a Am Zehnhoff-Dinnesen, Antoinette $u Department for Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhems University, Münster, Germany
700    1_
$a Kuonen, Rahel $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
700    1_
$a Weiss, Annette $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u Bavarian Care and Nursing Authority, Amberg, Germany
700    1_
$a Kepak, Tomas $u University Hospital Brno & International Clinical Research Center (FNUSA-ICRC), Masaryk University, Brno, Czech Republic
700    1_
$a Kruseova, Jarmila $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Berger, Claire $u Department of Pediatric Hematology and Oncology, University-Hospital, Saint-Étienne, France $u Lyon University, Jean Monnet University, INSERM U 1059, Sainbiose, Saint-Étienne, France
700    1_
$a Calaminus, Gabriele $u Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany
700    1_
$a Sommer, Grit $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u Department of Pediatric Endocrinology, Diabetology and Metabolism, Inselspital, Bern University Children's Hospital, University of Bern, Bern, Switzerland $u Department of BioMedical Research, University of Bern, Bern, Switzerland
700    1_
$a Kuehni, Claudia E $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland. claudia.kuehni@unibe.ch $u Division of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. claudia.kuehni@unibe.ch
710    2_
$a PanCareLIFE Consortium
773    0_
$w MED00210173 $t Journal of cancer survivorship $x 1932-2267 $g Roč. 19, č. 1 (2025), s. 162-173
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37736773 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135534 $b ABA008
999    __
$a ok $b bmc $g 2311500 $s 1247233
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 19 $c 1 $d 162-173 $e 20230922 $i 1932-2267 $m Journal of cancer survivorship $n J Cancer Surviv $x MED00210173
GRA    __
$a 602030 $p European Union's Seventh Framework Program
GRA    __
$a KLS-3412-02-2014 $p Krebsliga Schweiz
GRA    __
$a KFS-4157-02-2017 $p Swiss Cancer Research Foundation
GRA    __
$a 110298 $p German Cancer Aid
GRA    __
$a 7E13061 $p University Hospital of Brno from the Ministry of Education, Youth and Sports of the Czech Republic
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...